Ad
related to: immunogen
Search results
AbbVie's Immunogen Acquired Elahere Meets Primary Goal In Mid-Stage Study In Heavily Pretreated...
Benzinga· 38 minutes agoOn Thursday, AbbVie Inc ABBV released topline results from the Phase 2 PICCOLO trial evaluating...
AbbVie's ovarian cancer therapy succeeds in mid-stage trial
Reuters· 4 hours agoThe U.S. Food and Drug Administration had in March approved the treatment for use in patients with...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 21 hours agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 6 days agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...
Decoding HIV’s Defenses: Innovative Vaccine Strategy Shows Promise
SciTechDaily· 4 days agoResults from NIH-funded animal models will inform the development of vaccines for humans. Using...
ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Clinical Trials Arena via Yahoo Finance· 3 days ago“ADCs form a core part of our differentiated solid tumour pipeline. We have extensive experience and...
The Dividend Dominators: 3 Stocks That Will Make Your Portfolio Reign Supreme
InvestorPlace· 1 day agoThe timing is perfect for loading up on dividend stocks as market experts expect the S&P 500 to...
Dual Immunotherapy Improves Response Rates in Gynecologic Clear Cell Cancers
MedPage Today· 3 days agoAt a median follow-up of 11.3 months, the overall response rate (ORR) among the 30 patients who...